Cord blood stem cells therapy leads to successful stroke recovery

Cord blood stem cells therapy leads to successful stroke recovery

Saneron CCEL Therapeutics, a Cryo-Cell International affiliated company, along with a group of researchers and colleagues of the University of South Florida has participated in a new research study of human umbilical cord blood stem cell’s treatment of stroke. In collaboration with the Henry Ford Hospital’s Neurology Department, Saneron concluded that human umbilical cord blood stem cells have a positive neuro-restorative effect on the post-stroke brain in diabetic rats. 

 

Read More